Vertex Pharmaceuticals (VRTX) Cash from Operations Growth (5y) (2014 - 2026)
Vertex Pharmaceuticals (VRTX) Cash from Operations Growth (5y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Regeneron Pharmaceuticals | 63.59 Bn | 54.83 Bn | 3.31 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.17% |
| Dec 31, 2025 | 0.26% |
| Sep 30, 2025 | 6.46% |
| Jun 30, 2025 | 0.66% |
| Mar 31, 2025 | 0.08% |
| Dec 31, 2024 | 5.56% |
| Sep 30, 2024 | 32.55% |
| Jun 30, 2024 | -58.79% |
| Mar 31, 2024 | 32.10% |
| Dec 31, 2023 | -5.70% |
| Sep 30, 2023 | 27.17% |
| Jun 30, 2023 | 28.67% |
| Mar 31, 2023 | 28.92% |
| Dec 31, 2022 | 36.51% |
| Sep 30, 2022 | 41.23% |
| Jun 30, 2022 | 44.38% |
| Mar 31, 2022 | 29.19% |
| Dec 31, 2021 | 47.05% |
| Sep 30, 2021 | 69.82% |
| Jun 30, 2021 | -47.10% |